n3-LCPUFA enriched Intravenous Lipid Emulsion for Bronchopulmonary Dysplasia
This trial will compare two types of fat emulsions given to preterm infants to see if one type can lower the rate of bronchopulmonary dysplasia, a chronic lung condition.
- Bronchopulmonary Dysplasia
- Very Low Birthweight
6 Primary · 5 Secondary · Reporting Duration: 18-22 months corrected gestational
2 Treatment Groups
1 of 2
1 of 2
384 Total Participants · 2 Treatment Groups
Primary Treatment: n3-LCPUFA enriched Intravenous Lipid Emulsion · No Placebo Group · N/A
Who is running the clinical trial?
Age 1 - 48 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does my medical history make me a viable candidate to join this clinical study?
"In order to be accepted into this medical trial, prospective participants must have bronchopulmonary dysplasia and fall within the 1 Hour - 48 Hours age range. With 384 spots available in total, recruitment has already begun." - Anonymous Online Contributor
Is registration for this investigation accessible to participants?
"Affirmative. Clinicaltrials.gov indicates that this medical trial is currently recruiting and was first posted on December 16th 2019. The most recent update was made November 4th 2022, with a target of 384 participants to be recruited from one site." - Anonymous Online Contributor
What goals are researchers hoping to fulfill in this clinical trial?
"This clinical trial is testing lipid peroxidation over a three week period. Secondary outcomes include the incidence of severe intraventricular hemorrhage (IVH), weight gain velocity, and incidences of moderate to severe neurodevelopmental disability which includes motor impairment cerebral palsy (CP) or non-CP with a GMFCS level ≥2, BSID III cognitive scores below 70, bilateral blindness with vision <20/200, or permanent hearing loss that interferes with communication even when amplified." - Anonymous Online Contributor
Is this experiment inviting participants of advanced age?
"According to the inclusion criteria, infants and toddlers from 1 hour old up to 48 hours can participate in this trial. 85 studies are available for children under 18 years of age, while 19 studies can be accessed by those aged 65 or above." - Anonymous Online Contributor
How many individuals are currently being treated in this clinical research?
"Affirmative. Per the clinicaltrials.gov website, this research undertaking is presently in its recruitment phase since December 16th 2019 and was last updated on November 4th 2022. Aiming to sign up 384 individuals, it will take place at a single location." - Anonymous Online Contributor